Global Drug Discovery Software Market
Global Drug Discovery Software Market

Drug Discovery Software Comprehensive Study by Application (Pharmaceutical Industry, Biotechnology Industry), Deployment Mode (Cloud Based, Web Based), Organization Size (Small & Medium Size Organizations, Large Organizations), End Users (R&D scientists, Clinical trial organizers, managers, analysts) Players and Region - Global Market Outlook to 2025

Drug Discovery Software Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

May 2020 Edition 225 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Drug Discovery Software Market Scope
Drug discovery software is used to develop new pharmaceutical drugs and test whether a newly created drug will be effective in treating a particular disease. Drug discovery software automates and leverages innovative technology that significantly cuts down on the arduous process of drug development, testing, and going to market. Most drug discovery solutions offer screening, predictive analytics, modeling, simulation, and computational capabilities. Those functionalities help with tasks such as image analysis and clinical trial results submission, as well as ensuring accurate reproducibility. Researchers and scientists use drug discovery software to gain market intelligence, take advantage of advancements in drug design and synthesis, tackle evolving and adapting diseases, and maintain and manage the integrity of data as drugs transition from the discovery phase to the clinical trial phase.

The market study is segmented, by Application (Pharmaceutical Industry and Biotechnology Industry) and major geographies with country level break-up.

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Drug Discovery Software market throughout the predicted period.

Epocrates (United States), Thermo Scientific Nautilus LIMS (United States), ChemDraw (PerkinElmer) (United States), MicroTracker (Norway), DrugPatentWatch (United States), AutoDock (Scripps Research) (United States), Collaborative Drug Discovery Inc. (United States), DrugDev Spark (United States), DSG Drug Safety (United States) and PEPID PDC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Schrodinger Discovery Informatics Suite (United States), Advera Health (United States), American Gene Technologies (United States), Aurora Drug Discovery Software (United States) and BIOVIA Discovery Studio (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Drug Discovery Software market by Type, Application and Region.

On the basis of geography, the market of Drug Discovery Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On 11 April 2019, Springer Nature and DrugPatentWatch partner to provide patent information for drug database. Newly available patent information supports researchers in their strategic decision-making in drug discovery. Drug patent information can help key stakeholders in the drug discovery process understand the impact of patent expiry on the competitive landscape, or their market share. They may also be able to evaluate licensing opportunities and explore what opportunities exist for drugs without patent protection, as well as develop end-of-life strategies for their products.
On 27 July 2017, Cyrus Biotechnology, Inc., a Seattle-based biotechnology software firm offering an advanced computational tool for protein modeling and design to accelerate new drug discovery, today announced the closing of an USD 8 million total Series A financing. The investment was led by Trinity Ventures, with participation from OrbiMed Advisors, SpringRock Ventures, W Fund and individual investors. Cyrus Bench software is based on years of work in computational biophysics and the first software algorithms to design new proteins in a computer. It accelerates drug discovery at pharmaceutical and biotechnology firms, as well as new product development at synthetic biology, chemical and consumer products firms.


Market Trend
  • Rapidly Adoption of the Artificial Intelligence and Deep Learning Technology

Market Drivers
  • The Growing Pharmaceutical Industry Worldwide
  • Surged R&D Activities in the Pharmaceutical Industry
  • Growing Automation in the Drug Discovery Processes
  • The Increasing Demand for the COVID-19 Drug Discovery
  • The Upsurging Demand for the Drug Discovery Owing to the Expiration of Patents
  • The Software Helps Pharmaceutical Companies to Remain Competitive In the Drug Market

Opportunities
  • The Growing Demand for the Drug Discovery Software from the Asia Pacific Region


Challenges
  • Unknown Regulation Complications and Duplication Problems


Key Target Audience
Drug Discovery Software Key Companies, Potential Technology Investors, Regulatory & Government Bodies, Pharmaceutical Companies, Downstream Vendors and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Application
  • Pharmaceutical Industry
  • Biotechnology Industry
By Deployment Mode
  • Cloud Based
  • Web Based

By Organization Size
  • Small & Medium Size Organizations
  • Large Organizations

By End Users
  • R&D scientists
  • Clinical trial organizers, managers, analysts

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Growing Pharmaceutical Industry Worldwide
      • 3.2.2. Surged R&D Activities in the Pharmaceutical Industry
      • 3.2.3. Growing Automation in the Drug Discovery Processes
      • 3.2.4. The Increasing Demand for the COVID-19 Drug Discovery
      • 3.2.5. The Upsurging Demand for the Drug Discovery Owing to the Expiration of Patents
      • 3.2.6. The Software Helps Pharmaceutical Companies to Remain Competitive In the Drug Market
    • 3.3. Market Challenges
      • 3.3.1. Unknown Regulation Complications and Duplication Problems
    • 3.4. Market Trends
      • 3.4.1. Rapidly Adoption of the Artificial Intelligence and Deep Learning Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Discovery Software, by Application, Deployment Mode, Organization Size, End Users and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Drug Discovery Software (Value)
      • 5.2.1. Global Drug Discovery Software by: Application (Value)
        • 5.2.1.1. Pharmaceutical Industry
        • 5.2.1.2. Biotechnology Industry
      • 5.2.2. Global Drug Discovery Software by: Deployment Mode (Value)
        • 5.2.2.1. Cloud Based
        • 5.2.2.2. Web Based
      • 5.2.3. Global Drug Discovery Software by: Organization Size (Value)
        • 5.2.3.1. Small & Medium Size Organizations
        • 5.2.3.2. Large Organizations
      • 5.2.4. Global Drug Discovery Software by: End Users (Value)
        • 5.2.4.1. R&D scientists
        • 5.2.4.2. Clinical trial organizers, managers, analysts
      • 5.2.5. Global Drug Discovery Software Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Drug Discovery Software: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Epocrates (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Scientific Nautilus LIMS (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ChemDraw (PerkinElmer) (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. MicroTracker (Norway)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. DrugPatentWatch (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AutoDock (Scripps Research) (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Collaborative Drug Discovery Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. DrugDev Spark (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. DSG Drug Safety (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PEPID PDC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Drug Discovery Software Sale, by Application, Deployment Mode, Organization Size, End Users and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Drug Discovery Software (Value)
      • 7.2.1. Global Drug Discovery Software by: Application (Value)
        • 7.2.1.1. Pharmaceutical Industry
        • 7.2.1.2. Biotechnology Industry
      • 7.2.2. Global Drug Discovery Software by: Deployment Mode (Value)
        • 7.2.2.1. Cloud Based
        • 7.2.2.2. Web Based
      • 7.2.3. Global Drug Discovery Software by: Organization Size (Value)
        • 7.2.3.1. Small & Medium Size Organizations
        • 7.2.3.2. Large Organizations
      • 7.2.4. Global Drug Discovery Software by: End Users (Value)
        • 7.2.4.1. R&D scientists
        • 7.2.4.2. Clinical trial organizers, managers, analysts
      • 7.2.5. Global Drug Discovery Software Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Discovery Software: by Application(USD Million)
  • Table 2. Drug Discovery Software Pharmaceutical Industry , by Region USD Million (2014-2019)
  • Table 3. Drug Discovery Software Biotechnology Industry , by Region USD Million (2014-2019)
  • Table 4. Drug Discovery Software: by Deployment Mode(USD Million)
  • Table 5. Drug Discovery Software Cloud Based , by Region USD Million (2014-2019)
  • Table 6. Drug Discovery Software Web Based , by Region USD Million (2014-2019)
  • Table 7. Drug Discovery Software: by Organization Size(USD Million)
  • Table 8. Drug Discovery Software Small & Medium Size Organizations , by Region USD Million (2014-2019)
  • Table 9. Drug Discovery Software Large Organizations , by Region USD Million (2014-2019)
  • Table 10. Drug Discovery Software: by End Users(USD Million)
  • Table 11. Drug Discovery Software R&D scientists , by Region USD Million (2014-2019)
  • Table 12. Drug Discovery Software Clinical trial organizers, managers, analysts , by Region USD Million (2014-2019)
  • Table 13. South America Drug Discovery Software, by Country USD Million (2014-2019)
  • Table 14. South America Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 15. South America Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 16. South America Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 17. South America Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 18. Brazil Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 19. Brazil Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 20. Brazil Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 21. Brazil Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 22. Argentina Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 23. Argentina Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 24. Argentina Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 25. Argentina Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 26. Rest of South America Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 27. Rest of South America Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 28. Rest of South America Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 29. Rest of South America Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 30. Asia Pacific Drug Discovery Software, by Country USD Million (2014-2019)
  • Table 31. Asia Pacific Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 32. Asia Pacific Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 33. Asia Pacific Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 34. Asia Pacific Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 35. China Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 36. China Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 37. China Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 38. China Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 39. Japan Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 40. Japan Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 41. Japan Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 42. Japan Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 43. India Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 44. India Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 45. India Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 46. India Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 47. South Korea Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 48. South Korea Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 49. South Korea Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 50. South Korea Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 51. Taiwan Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 52. Taiwan Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 53. Taiwan Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 54. Taiwan Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 55. Australia Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 56. Australia Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 57. Australia Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 58. Australia Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 59. Rest of Asia-Pacific Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 60. Rest of Asia-Pacific Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 61. Rest of Asia-Pacific Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 62. Rest of Asia-Pacific Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 63. Europe Drug Discovery Software, by Country USD Million (2014-2019)
  • Table 64. Europe Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 65. Europe Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 66. Europe Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 67. Europe Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 68. Germany Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 69. Germany Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 70. Germany Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 71. Germany Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 72. France Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 73. France Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 74. France Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 75. France Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 76. Italy Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 77. Italy Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 78. Italy Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 79. Italy Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 80. United Kingdom Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 81. United Kingdom Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 82. United Kingdom Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 83. United Kingdom Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 84. Netherlands Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 85. Netherlands Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 86. Netherlands Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 87. Netherlands Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 88. Rest of Europe Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 89. Rest of Europe Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 90. Rest of Europe Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 91. Rest of Europe Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 92. MEA Drug Discovery Software, by Country USD Million (2014-2019)
  • Table 93. MEA Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 94. MEA Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 95. MEA Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 96. MEA Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 97. Middle East Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 98. Middle East Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 99. Middle East Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 100. Middle East Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 101. Africa Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 102. Africa Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 103. Africa Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 104. Africa Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 105. North America Drug Discovery Software, by Country USD Million (2014-2019)
  • Table 106. North America Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 107. North America Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 108. North America Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 109. North America Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 110. United States Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 111. United States Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 112. United States Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 113. United States Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 114. Canada Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 115. Canada Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 116. Canada Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 117. Canada Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 118. Mexico Drug Discovery Software, by Application USD Million (2014-2019)
  • Table 119. Mexico Drug Discovery Software, by Deployment Mode USD Million (2014-2019)
  • Table 120. Mexico Drug Discovery Software, by Organization Size USD Million (2014-2019)
  • Table 121. Mexico Drug Discovery Software, by End Users USD Million (2014-2019)
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Drug Discovery Software: by Application(USD Million)
  • Table 133. Drug Discovery Software Pharmaceutical Industry , by Region USD Million (2020-2025)
  • Table 134. Drug Discovery Software Biotechnology Industry , by Region USD Million (2020-2025)
  • Table 135. Drug Discovery Software: by Deployment Mode(USD Million)
  • Table 136. Drug Discovery Software Cloud Based , by Region USD Million (2020-2025)
  • Table 137. Drug Discovery Software Web Based , by Region USD Million (2020-2025)
  • Table 138. Drug Discovery Software: by Organization Size(USD Million)
  • Table 139. Drug Discovery Software Small & Medium Size Organizations , by Region USD Million (2020-2025)
  • Table 140. Drug Discovery Software Large Organizations , by Region USD Million (2020-2025)
  • Table 141. Drug Discovery Software: by End Users(USD Million)
  • Table 142. Drug Discovery Software R&D scientists , by Region USD Million (2020-2025)
  • Table 143. Drug Discovery Software Clinical trial organizers, managers, analysts , by Region USD Million (2020-2025)
  • Table 144. South America Drug Discovery Software, by Country USD Million (2020-2025)
  • Table 145. South America Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 146. South America Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 147. South America Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 148. South America Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 149. Brazil Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 150. Brazil Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 151. Brazil Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 152. Brazil Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 153. Argentina Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 154. Argentina Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 155. Argentina Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 156. Argentina Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 157. Rest of South America Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 158. Rest of South America Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 159. Rest of South America Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 160. Rest of South America Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 161. Asia Pacific Drug Discovery Software, by Country USD Million (2020-2025)
  • Table 162. Asia Pacific Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 163. Asia Pacific Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 164. Asia Pacific Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 165. Asia Pacific Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 166. China Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 167. China Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 168. China Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 169. China Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 170. Japan Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 171. Japan Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 172. Japan Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 173. Japan Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 174. India Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 175. India Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 176. India Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 177. India Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 178. South Korea Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 179. South Korea Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 180. South Korea Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 181. South Korea Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 182. Taiwan Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 183. Taiwan Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 184. Taiwan Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 185. Taiwan Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 186. Australia Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 187. Australia Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 188. Australia Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 189. Australia Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 190. Rest of Asia-Pacific Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 191. Rest of Asia-Pacific Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 192. Rest of Asia-Pacific Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 193. Rest of Asia-Pacific Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 194. Europe Drug Discovery Software, by Country USD Million (2020-2025)
  • Table 195. Europe Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 196. Europe Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 197. Europe Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 198. Europe Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 199. Germany Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 200. Germany Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 201. Germany Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 202. Germany Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 203. France Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 204. France Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 205. France Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 206. France Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 207. Italy Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 208. Italy Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 209. Italy Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 210. Italy Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 211. United Kingdom Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 212. United Kingdom Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 213. United Kingdom Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 214. United Kingdom Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 215. Netherlands Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 216. Netherlands Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 217. Netherlands Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 218. Netherlands Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 219. Rest of Europe Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 220. Rest of Europe Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 221. Rest of Europe Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 222. Rest of Europe Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 223. MEA Drug Discovery Software, by Country USD Million (2020-2025)
  • Table 224. MEA Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 225. MEA Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 226. MEA Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 227. MEA Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 228. Middle East Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 229. Middle East Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 230. Middle East Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 231. Middle East Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 232. Africa Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 233. Africa Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 234. Africa Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 235. Africa Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 236. North America Drug Discovery Software, by Country USD Million (2020-2025)
  • Table 237. North America Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 238. North America Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 239. North America Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 240. North America Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 241. United States Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 242. United States Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 243. United States Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 244. United States Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 245. Canada Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 246. Canada Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 247. Canada Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 248. Canada Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 249. Mexico Drug Discovery Software, by Application USD Million (2020-2025)
  • Table 250. Mexico Drug Discovery Software, by Deployment Mode USD Million (2020-2025)
  • Table 251. Mexico Drug Discovery Software, by Organization Size USD Million (2020-2025)
  • Table 252. Mexico Drug Discovery Software, by End Users USD Million (2020-2025)
  • Table 253. Research Programs/Design for This Report
  • Table 254. Key Data Information from Secondary Sources
  • Table 255. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Discovery Software: by Application USD Million (2014-2019)
  • Figure 5. Global Drug Discovery Software: by Deployment Mode USD Million (2014-2019)
  • Figure 6. Global Drug Discovery Software: by Organization Size USD Million (2014-2019)
  • Figure 7. Global Drug Discovery Software: by End Users USD Million (2014-2019)
  • Figure 8. South America Drug Discovery Software Share (%), by Country
  • Figure 9. Asia Pacific Drug Discovery Software Share (%), by Country
  • Figure 10. Europe Drug Discovery Software Share (%), by Country
  • Figure 11. MEA Drug Discovery Software Share (%), by Country
  • Figure 12. North America Drug Discovery Software Share (%), by Country
  • Figure 13. Global Drug Discovery Software share by Players 2019 (%)
  • Figure 14. Global Drug Discovery Software share by Players (Top 3) 2019(%)
  • Figure 15. Global Drug Discovery Software share by Players (Top 5) 2019(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Epocrates (United States) Revenue, Net Income and Gross profit
  • Figure 18. Epocrates (United States) Revenue: by Geography 2019
  • Figure 19. Thermo Scientific Nautilus LIMS (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Scientific Nautilus LIMS (United States) Revenue: by Geography 2019
  • Figure 21. ChemDraw (PerkinElmer) (United States) Revenue, Net Income and Gross profit
  • Figure 22. ChemDraw (PerkinElmer) (United States) Revenue: by Geography 2019
  • Figure 23. MicroTracker (Norway) Revenue, Net Income and Gross profit
  • Figure 24. MicroTracker (Norway) Revenue: by Geography 2019
  • Figure 25. DrugPatentWatch (United States) Revenue, Net Income and Gross profit
  • Figure 26. DrugPatentWatch (United States) Revenue: by Geography 2019
  • Figure 27. AutoDock (Scripps Research) (United States) Revenue, Net Income and Gross profit
  • Figure 28. AutoDock (Scripps Research) (United States) Revenue: by Geography 2019
  • Figure 29. Collaborative Drug Discovery Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Collaborative Drug Discovery Inc. (United States) Revenue: by Geography 2019
  • Figure 31. DrugDev Spark (United States) Revenue, Net Income and Gross profit
  • Figure 32. DrugDev Spark (United States) Revenue: by Geography 2019
  • Figure 33. DSG Drug Safety (United States) Revenue, Net Income and Gross profit
  • Figure 34. DSG Drug Safety (United States) Revenue: by Geography 2019
  • Figure 35. PEPID PDC (United States) Revenue, Net Income and Gross profit
  • Figure 36. PEPID PDC (United States) Revenue: by Geography 2019
  • Figure 37. Global Drug Discovery Software: by Application USD Million (2020-2025)
  • Figure 38. Global Drug Discovery Software: by Deployment Mode USD Million (2020-2025)
  • Figure 39. Global Drug Discovery Software: by Organization Size USD Million (2020-2025)
  • Figure 40. Global Drug Discovery Software: by End Users USD Million (2020-2025)
  • Figure 41. South America Drug Discovery Software Share (%), by Country
  • Figure 42. Asia Pacific Drug Discovery Software Share (%), by Country
  • Figure 43. Europe Drug Discovery Software Share (%), by Country
  • Figure 44. MEA Drug Discovery Software Share (%), by Country
  • Figure 45. North America Drug Discovery Software Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Epocrates (United States)
  • Thermo Scientific Nautilus LIMS (United States)
  • ChemDraw (PerkinElmer) (United States)
  • MicroTracker (Norway)
  • DrugPatentWatch (United States)
  • AutoDock (Scripps Research) (United States)
  • Collaborative Drug Discovery Inc. (United States)
  • DrugDev Spark (United States)
  • DSG Drug Safety (United States)
  • PEPID PDC (United States)
Additional players considered in the study are as follows:
Schrodinger Discovery Informatics Suite (United States) , Advera Health (United States) , American Gene Technologies (United States) , Aurora Drug Discovery Software (United States) , BIOVIA Discovery Studio (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation